| Literature DB >> 81415 |
G Remuzzi, R Misiani, D Marchesi, M Livio, G Mecca, G de Gaetano, M B Donati.
Abstract
It is suggested that patients with the haemolytic-uraemic syndrome and related disorders (such as thrombotic thrombocytopenic purpura) lack a plasma factor which stimulates prostacyclin (P.G.I2) activity. Normal plasma would supply the missing factor and is a rational treatment for some life-threatening symptoms (thrombocytopenia, haemolytic anaemia, hypertension) of this syndrome.Entities:
Mesh：
Substances：
Year: 1978 PMID： 81415 DOI： 10.1016/s0140-6736(78)91573-8
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321